Hims & Hers Health, Inc.

Below is Validea's guru fundamental report for HIMS & HERS HEALTH INC (HIMS). Of the 22 guru strategies we follow, HIMS rates highest using our P/B Growth Investor model based on the published strategy of Partha Mohanram. This growth model looks for low book-to-market stocks that exhibit characteristics associated with sustained future growth.
HIMS & HERS HEALTH INC (HIMS) is a mid-cap growth stock in the Biotechnology & Drugs industry. The rating using this strategy is 77% based on the firm’s underlying fundamentals and the stock’s valuation. A score of 80% or above typically indicates that the strategy has some interest in the stock and a score above 90% typically indicates strong interest.
The following table summarizes whether the stock meets each of this strategy's tests. Not all criteria in the below table receive equal weighting or are independent, but the table provides a brief overview of the strong and weak points of the security in the context of the strategy's criteria.
Detailed Analysis of HIMS & HERS HEALTH INC
More Information on Partha Mohanram
About Partha Mohanram: Sometimes the best investing strategies don't come from the world of investing. Sometimes research that changes the investing world can come from the halls of academia. Partha Mohanram is a great example of this. While academic research has shown that value investing works over time, it has found the opposite for growth investing. Mohanram turned that research on its head by developing a growth model that produced significant market outperformance. His research paper "Separating Winners from Losers among Low Book-to-Market Stocks using Financial Statement Analysis" looked at the criteria that can be used to separate growth stocks that continue their upward trajectory from those that don't. Mohanram is currently the John H. Watson Chair in Value Investing at the University of Toronto and was previously an Associate Professor at the Columbia Business School.
Additional Research Links
Dividend Aristocrats 2025
Wide Moat Stocks
High Insider Ownership Stocks
About Validea: Validea is aninvestment researchservice that follows the published strategies of investment legends. Validea offers both stock analysis and model portfolios based on gurus who have outperformed the market over the long-term, including Warren Buffett, Benjamin Graham, Peter Lynch and Martin Zweig. For more information about Validea, click here
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Validea Detailed Fundamental Analysis - HIMS

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Hims & Hers Health Inc (Symbol: HIMS), where a total volume of 214,020 contracts has been traded thus far today, a contract volume which is representative of approximately 21.4 million underlying shares (given that every 1 contract represents 100 underlying shares). That number works out to 69.1% of HIMS's average daily trading volume over the past month, of 31.0 million shares. Particularly high volume was seen for the $53 strike call option expiring October 31, 2025, with 13,247 contracts trading so far today, representing approximately 1.3 million underlying shares of HIMS. Below is a chart showing HIMS's trailing twelve month trading history, with the $53 strike highlighted in orange:
Teekay Corporation Ltd (Symbol: TK) options are showing a volume of 3,927 contracts thus far today. That number of contracts represents approximately 392,700 underlying shares, working out to a sizeable 69% of TK's average daily trading volume over the past month, of 569,085 shares. Especially high volume was seen for the $10 strike call option expiring January 16, 2026, with 3,558 contracts trading so far today, representing approximately 355,800 underlying shares of TK. Below is a chart showing TK's trailing twelve month trading history, with the $10 strike highlighted in orange:
And Comfort Systems USA Inc (Symbol: FIX) options are showing a volume of 2,175 contracts thus far today. That number of contracts represents approximately 217,500 underlying shares, working out to a sizeable 63.4% of FIX's average daily trading volume over the past month, of 343,300 shares. Particularly high volume was seen for the $830 strike call option expiring November 21, 2025, with 155 contracts trading so far today, representing approximately 15,500 underlying shares of FIX. Below is a chart showing FIX's trailing twelve month trading history, with the $830 strike highlighted in orange:
For the various different available expirations for HIMS options, TK options, or FIX options, visit StockOptionsChannel.com.
Also see:
Cheap Materials Stocks
Top Ten Hedge Funds Holding UTHY
Top Ten Hedge Funds Holding HECA
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Notable Friday Option Activity: HIMS, TK, FIX

Below is Validea's guru fundamental report for HIMS & HERS HEALTH INC (HIMS). Of the 22 guru strategies we follow, HIMS rates highest using our P/B Growth Investor model based on the published strategy of Partha Mohanram. This growth model looks for low book-to-market stocks that exhibit characteristics associated with sustained future growth.
HIMS & HERS HEALTH INC (HIMS) is a mid-cap growth stock in the Biotechnology & Drugs industry. The rating using this strategy is 77% based on the firm’s underlying fundamentals and the stock’s valuation. A score of 80% or above typically indicates that the strategy has some interest in the stock and a score above 90% typically indicates strong interest.
The following table summarizes whether the stock meets each of this strategy's tests. Not all criteria in the below table receive equal weighting or are independent, but the table provides a brief overview of the strong and weak points of the security in the context of the strategy's criteria.
Detailed Analysis of HIMS & HERS HEALTH INC
More Information on Partha Mohanram
About Partha Mohanram: Sometimes the best investing strategies don't come from the world of investing. Sometimes research that changes the investing world can come from the halls of academia. Partha Mohanram is a great example of this. While academic research has shown that value investing works over time, it has found the opposite for growth investing. Mohanram turned that research on its head by developing a growth model that produced significant market outperformance. His research paper "Separating Winners from Losers among Low Book-to-Market Stocks using Financial Statement Analysis" looked at the criteria that can be used to separate growth stocks that continue their upward trajectory from those that don't. Mohanram is currently the John H. Watson Chair in Value Investing at the University of Toronto and was previously an Associate Professor at the Columbia Business School.
Additional Research Links
Dividend Aristocrats 2024
Wide Moat Stocks
High Insider Ownership Stocks
About Validea: Validea is aninvestment researchservice that follows the published strategies of investment legends. Validea offers both stock analysis and model portfolios based on gurus who have outperformed the market over the long-term, including Warren Buffett, Benjamin Graham, Peter Lynch and Martin Zweig. For more information about Validea, click here
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

The NASDAQ 100 After Hours Indicator is down -35.67 to 25,091.46. The total After hours volume is currently 148,172,897 shares traded.
The following are the most active stocks for the after hours session:
Hims & Hers Health, Inc. (HIMS) is -0.1138 at $49.25, with 4,554,673 shares traded. HIMS's current last sale is 108.23% of the target price of $45.5.
PPL Corporation (PPL) is unchanged at $37.52, with 2,990,445 shares traded. Over the last four weeks they have had 3 up revisions for the earnings forecast, for the fiscal quarter ending Dec 2025. The consensus EPS forecast is $0.43. As reported by Zacks, the current mean recommendation for PPL is in the "buy range".
Oklo Inc. (OKLO) is -0.14 at $139.30, with 2,686,161 shares traded. OKLO's current last sale is 163.88% of the target price of $85.
Clearwater Analytics Holdings, Inc. (CWAN) is unchanged at $19.04, with 2,564,414 shares traded. As reported by Zacks, the current mean recommendation for CWAN is in the "buy range".
Polaris Inc. (PII) is unchanged at $66.90, with 1,947,033 shares traded.PII is scheduled to provide an earnings report on 10/28/2025, for the fiscal quarter ending Sep2025. The consensus earnings per share forecast is 0.18 per share, which represents a 73 percent increase over the EPS one Year Ago
Ford Motor Company (F) is -0.0198 at $12.54, with 1,832,250 shares traded.F is scheduled to provide an earnings report on 10/23/2025, for the fiscal quarter ending Sep2025. The consensus earnings per share forecast is 0.38 per share, which represents a 49 percent increase over the EPS one Year Ago
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

After Hours Most Active for Oct 21, 2025 : HIMS, PPL, OKLO, CWAN, PII, F

Below is Validea's guru fundamental report for HIMS & HERS HEALTH INC (HIMS). Of the 22 guru strategies we follow, HIMS rates highest using our Small-Cap Growth Investor model based on the published strategy of Motley Fool. This strategy looks for small cap growth stocks with solid fundamentals and strong price performance.
HIMS & HERS HEALTH INC (HIMS) is a mid-cap growth stock in the Biotechnology & Drugs industry. The rating using this strategy is 81% based on the firm’s underlying fundamentals and the stock’s valuation. A score of 80% or above typically indicates that the strategy has some interest in the stock and a score above 90% typically indicates strong interest.
The following table summarizes whether the stock meets each of this strategy's tests. Not all criteria in the below table receive equal weighting or are independent, but the table provides a brief overview of the strong and weak points of the security in the context of the strategy's criteria.
Detailed Analysis of HIMS & HERS HEALTH INC
More Information on Motley Fool
About Motley Fool: Brothers David and Tom Gardner often wear funny hats in public appearances, but they're hardly fools -- at least not the kind whose advice you should readily dismiss. The Gardners are the founders of the popular Motley Fool web site, which offers frank and often irreverent commentary on investing, the stock market, and personal finance. The Gardners' "Fool" really is a multi-media endeavor, offering not only its web content but also several books written by the brothers, a weekly syndicated newspaper column, and subscription newsletter services.
Additional Research Links
Dividend Aristocrats 2025
Wide Moat Stocks
About Validea: Validea is aninvestment researchservice that follows the published strategies of investment legends. Validea offers both stock analysis and model portfolios based on gurus who have outperformed the market over the long-term, including Warren Buffett, Benjamin Graham, Peter Lynch and Martin Zweig. For more information about Validea, click here
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

HIMS Quantitative Stock Analysis

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Carvana Co (Symbol: CVNA), where a total volume of 28,215 contracts has been traded thus far today, a contract volume which is representative of approximately 2.8 million underlying shares (given that every 1 contract represents 100 underlying shares). That number works out to 102% of CVNA's average daily trading volume over the past month, of 2.8 million shares. Particularly high volume was seen for the $330 strike call option expiring October 31, 2025, with 1,803 contracts trading so far today, representing approximately 180,300 underlying shares of CVNA. Below is a chart showing CVNA's trailing twelve month trading history, with the $330 strike highlighted in orange:
Hims & Hers Health Inc (Symbol: HIMS) options are showing a volume of 274,622 contracts thus far today. That number of contracts represents approximately 27.5 million underlying shares, working out to a sizeable 97.3% of HIMS's average daily trading volume over the past month, of 28.2 million shares. Particularly high volume was seen for the $65 strike call option expiring October 24, 2025, with 17,526 contracts trading so far today, representing approximately 1.8 million underlying shares of HIMS. Below is a chart showing HIMS's trailing twelve month trading history, with the $65 strike highlighted in orange:
And Western Alliance Bancorporation (Symbol: WAL) options are showing a volume of 12,957 contracts thus far today. That number of contracts represents approximately 1.3 million underlying shares, working out to a sizeable 90.2% of WAL's average daily trading volume over the past month, of 1.4 million shares. Especially high volume was seen for the $55 strike put option expiring December 19, 2025, with 3,234 contracts trading so far today, representing approximately 323,400 underlying shares of WAL. Below is a chart showing WAL's trailing twelve month trading history, with the $55 strike highlighted in orange:
For the various different available expirations for CVNA options, HIMS options, or WAL options, visit StockOptionsChannel.com.
Also see:
Dividend ETFs
ORKA Average Annual Return
Funds Holding DTO
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Noteworthy Thursday Option Activity: CVNA, HIMS, WAL

Shares of Hims & Hers (NYSE: HIMS) jumped 9% in trading on Wednesday after the company announced an expansion into menopause and perimenopause specialties on the Hers app. This is the kind of product expansion that will drive greater adoption and higher growth long term, as Travis Hoium highlights in this video.
*Stock prices used were end-of-day prices of Oct. 15, 2025. The video was published on Oct. 15, 2025.
Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Continue »
Should you invest $1,000 in Hims & Hers Health right now?
Before you buy stock in Hims & Hers Health, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Hims & Hers Health wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $655,428!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,103,559!*
Now, it’s worth noting Stock Advisor’s total average return is 1,060% — a market-crushing outperformance compared to 189% for the S&P 500. Don’t miss out on the latest top 10 list, available when you join Stock Advisor.
*Stock Advisor returns as of October 13, 2025
Travis Hoium has positions in Hims & Hers Health. The Motley Fool has positions in and recommends Hims & Hers Health. The Motley Fool has a disclosure policy. Travis Hoium is an affiliate of The Motley Fool and may be compensated for promoting its services. If you choose to subscribe through their link they will earn some extra money that supports their channel. Their opinions remain their own and are unaffected by The Motley Fool.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Hims & Hers Stock Jumps 9% After Huge Announcement

These two healthcare companies are interesting choices for long-term investors, but only one can be the better investment in this comparison.
Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now, when you join Stock Advisor. See the stocks »
*Stock prices used were the afternoon prices of Oct. 11, 2025. The video was published on Oct. 13, 2025.
Should you invest $1,000 in UnitedHealth Group right now?
Before you buy stock in UnitedHealth Group, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and UnitedHealth Group wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $657,979!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,122,746!*
Now, it’s worth noting Stock Advisor’s total average return is 1,060% — a market-crushing outperformance compared to 187% for the S&P 500. Don’t miss out on the latest top 10 list, available when you join Stock Advisor.
*Stock Advisor returns as of October 13, 2025
Parkev Tatevosian, CFA has no position in any of the stocks mentioned. The Motley Fool recommends UnitedHealth Group. The Motley Fool has a disclosure policy. Parkev Tatevosian is an affiliate of The Motley Fool and may be compensated for promoting its services. If you choose to subscribe through his link, he will earn some extra money that supports his channel. His opinions remain his own and are unaffected by The Motley Fool.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Should Investors Buy UnitedHealth Stock Instead of Hims & Hers Stock?

The NASDAQ 100 After Hours Indicator is up 18.83 to 25,155.45. The total After hours volume is currently 209,246,711 shares traded.
The following are the most active stocks for the after hours session:
IonQ, Inc. (IONQ) is +0.31 at $74.61, with 5,851,071 shares traded., following a 52-week high recorded in today's regular session.
Hims & Hers Health, Inc. (HIMS) is +0.03 at $58.20, with 5,430,105 shares traded. HIMS's current last sale is 127.91% of the target price of $45.5.
HP Inc. (HPQ) is -0.05 at $26.98, with 3,148,561 shares traded. HPQ's current last sale is 95.84% of the target price of $28.15.
Flagstar Financial, Inc. (FLG) is unchanged at $11.96, with 2,727,261 shares traded. FLG's current last sale is 85.43% of the target price of $14.
Oklo Inc. (OKLO) is -0.47 at $134.30, with 2,577,610 shares traded. OKLO's current last sale is 159.88% of the target price of $84.
Coterra Energy Inc. (CTRA) is unchanged at $24.23, with 2,513,177 shares traded. As reported by Zacks, the current mean recommendation for CTRA is in the "buy range".
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

After Hours Most Active for Oct 8, 2025 : IONQ, HIMS, HPQ, FLG, OKLO, CTRA

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in SkyWater Technology Inc (Symbol: SKYT), where a total of 13,736 contracts have traded so far, representing approximately 1.4 million underlying shares. That amounts to about 62.4% of SKYT's average daily trading volume over the past month of 2.2 million shares. Particularly high volume was seen for the $22 strike call option expiring October 10, 2025, with 6,399 contracts trading so far today, representing approximately 639,900 underlying shares of SKYT. Below is a chart showing SKYT's trailing twelve month trading history, with the $22 strike highlighted in orange:
PepsiCo Inc (Symbol: PEP) saw options trading volume of 43,181 contracts, representing approximately 4.3 million underlying shares or approximately 62.3% of PEP's average daily trading volume over the past month, of 6.9 million shares. Especially high volume was seen for the $145 strike call option expiring January 16, 2026, with 2,158 contracts trading so far today, representing approximately 215,800 underlying shares of PEP. Below is a chart showing PEP's trailing twelve month trading history, with the $145 strike highlighted in orange:
And Hims & Hers Health Inc (Symbol: HIMS) options are showing a volume of 158,495 contracts thus far today. That number of contracts represents approximately 15.8 million underlying shares, working out to a sizeable 54.3% of HIMS's average daily trading volume over the past month, of 29.2 million shares. Especially high volume was seen for the $60 strike call option expiring October 10, 2025, with 26,520 contracts trading so far today, representing approximately 2.7 million underlying shares of HIMS. Below is a chart showing HIMS's trailing twelve month trading history, with the $60 strike highlighted in orange:
For the various different available expirations for SKYT options, PEP options, or HIMS options, visit StockOptionsChannel.com.
Also see:
SHFS Average Annual Return
FRLN Videos
Top Ten Hedge Funds Holding TAXI
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Indicator	TTM Median
P/E	292.63 23.75
Price/Sales	4.87 3.01
P/B	14.02 2.20
P/FCF	52.29 18.30

Indicator	TTM Median
ROE	4.93 25.41
ROA	3.81 6.00
Net Worth	5.50 0.20
Quick Ratio	2.30 1.71
Current Ratio	2.68 2.83

Indicator	TTM Median
Net Profit Margin	1.59 10.25
Operating Margin	1.12 14.24
Gross Margin	82.12 68.59
Return on tangible equity	7.88 53.53

Indicator	TTM Median
EPS	0.06 0.37
EPS Forecast	0.06 0.37
Revenue	402.00M 16.00M
Gross Profit	318.00M —
EBITDA	13.00M —

Hims & Hers Health, Inc.

TTM metrics for the latest quarter under IFRS and their historical dynamics

Valuation

Debts

Efficiency

Other ratios

Revenue